---
tags:
  - diabetes
  - endocrine
aliases:
---
HbA1c target < 48 (i.e. Pre-diabetic levels are acceptable)
*See NICE Flowchart: [NICE](https://www.nice.org.uk/guidance/ng28) *  

*See [[diabetes- antidiabetic drugs]].* 
# Treatment based on target levels
If new diagnosis: Lifestyle advice
	Exercise: 30 mins moderate intensity physical activity 5 times/week.
If Lifestyle modification but still
	HbA1c > 48: Start 1 drug (Metformin). Target for adding another drug is 58.
	If instead of Metformin, sulphonylurea is started as 1st drug, target will be 53 instead of 58.
If already on metformin (or Metformin c/i), but
	HbA1c 48 - 58: Reinforce advice about Lifestyle modification.
	HbA1c > 58: 2nd drug (aka first intensification) and now target: 53.
		- metformin + DPP-4 inhibitor (gliptin)
		- metformin + pioglitazone 
		- metformin + sulfonylurea 
		- metformin + SGLT-2 inhibitor (if [[diabetes- antidiabetic drugs#Glucose excretion|NICE criteria]] met)

If still not controlled, 2nd intensification. Or if other drugs c/i: consider insulin
- metformin + DPP-4 inhibitor + sulfonylurea
- metformin + pioglitazone + sulfonylurea
- metformin + (pioglitazone or sulfonylurea or DPP-4 inhibitor) + SGLT-2 if certain NICE criteria are met
- insulin-based treatment

# Treatment based on appropriate drug to use
If high risk of CVD/established CVD/HF -> Metformin, once established, add SGLT-2 inhibitor  

If no risk of HF: Metformin
## Scenario:  
If Metformin not tolerated -> Modified release Metformin.  
If Metformin C/I
- If risk of CVD -> SGLT-2 monotherapy
- If not high risk CVD/no HF -> DPP4 inhibitor/Pioglitazone/Sulfonylurea.

|                                                                                                   |                                                                                                                                                                                 |
| ------------------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Uncontrolled DM 2 despite lifestyle changes + eGFR <30 + h/o of Heart Failure + BMI >= 30 (obese) | Give Insulin                                                                                                                                                                    |
| DM2 in obese with impaired RFT                                                                    | Give insulin or gliptins (DDP4 inhibitors. Avoid this if HF)                                                                                                                    |
| If DM with obese only                                                                             | start metformin.                                                                                                                                                                |
| If DM with impaired renal only                                                                    | Gliptins, Repaglinide.                                                                                                                                                          |
| Beta 2 agonists (Salbutamol)                                                                      | can cause hyperglycemia, & hypokalemia so monitor.                                                                                                                              |
| Beta blockers                                                                                     | cause hypoglycemia. They can also mask features of hypoglycemia like tachycardia, sweating.                                                                                     |
| All diabetics with confirmed microalbuminuria (& eGFR > 30)                                       | Give [[ace inhibitors\|ACE]]i even if normotensive > Atorvastatin 20mg (irrespective of lipid profile). Metformin commenced based on results of lifestyle modification & HbA1c. |
